BioNTech SE annual capital expenditures (capex)
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioNTech SE Capital Expenditures (CapEx) Growth & History (BNTX)
BioNTech SE's capital expenditures (capex) was €175.1M for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €175.1M | −€111.4M | −38.88% |
| 2024 | 2024-12-31 | €286.5M | €37.1M | +14.88% |
| 2023 | 2023-12-31 | €249.4M | −€79.8M | −24.24% |
| 2022 | 2022-12-31 | €329.2M | €201.7M | +158.20% |
| 2021 | 2021-12-31 | €127.5M | €61.5M | +93.18% |
| 2020 | 2020-12-31 | €66.0M | €27.4M | +70.98% |
| 2019 | 2019-12-31 | €38.6M | €8.7M | +29.09% |
| 2018 | 2018-12-31 | €29.9M | €5.6M | +22.95% |
| 2017 | 2017-12-31 | €24.3M | — | — |
BioNTech SE quarterly capital expenditures (capex)
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €55.4M | €25.2M | +83.44% |
| Q1 2026 | 2026-03-31 | €78.9M | — | — |
| Q4 2025 | 2025-12-31 | €62.1M | — | — |
| Q3 2025 | 2025-09-30 | €38.6M | — | — |
| Q2 2025 | 2025-06-30 | €30.2M | — | — |
BioNTech SE capital expenditures (capex) trends
Over the last five fiscal years, BioNTech SE's capital expenditures (capex) increased from €66.0M to €175.1M, a change of €109.1M. The latest reported quarter, Q2 2026, shows €55.4M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗